Endometrial cancer medical therapy

Jump to navigation Jump to search

Endometrial cancer Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Endometrial cancer from other Diseases

Epidemiology and Demographics

Risk factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Endometrial cancer medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Endometrial cancer medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Endometrial cancer medical therapy

CDC on Endometrial cancer medical therapy

Endometrial cancer medical therapy in the news

Blogs on Endometrial cancer medical therapy

Directions to Hospitals Treating Endometrial cancer

Risk calculators and risk factors for Endometrial cancer medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Roukoz A. Karam, M.D.[2]

Overview

The optimal therapy for endometrial cancer depends on the stage at diagnosis. A combination of chemotherapy and radiation therapy is indicated in stages IIIB- IV.

Medical Therapy

  • The optimal therapy for endometrial cancer depends on the stage at diagnosis. A combination of chemotherapy and radiation therapy is indicated in stages IIIB- IV.
  • Chemotherapy is not the first-line treatment option for patients with stage I-III endometrial cancer. Surgery is the mainstay of treatment.
  • Chemotherapy without prior surgery is usually reserved for patients with stage IV endometrial cancer or patients that are not surgical candidates.

References

  1. Fleming GF (2007). "Systemic chemotherapy for uterine carcinoma: metastatic and adjuvant". J Clin Oncol. 25 (20): 2983–90. doi:10.1200/JCO.2007.10.8431. PMID 17617530.
  2. Decruze SB, Green JA (2007). "Hormone therapy in advanced and recurrent endometrial cancer: a systematic review". Int J Gynecol Cancer. 17 (5): 964–78. doi:10.1111/j.1525-1438.2007.00897.x. PMID 17442022.


Template:WikiDoc Sources